271 related articles for article (PubMed ID: 18245811)
1. Controlled delivery of T-box21 small interfering RNA ameliorates autoimmune alopecia (Alopecia Areata) in a C3H/HeJ mouse model.
Nakamura M; Jo J; Tabata Y; Ishikawa O
Am J Pathol; 2008 Mar; 172(3):650-8. PubMed ID: 18245811
[TBL] [Abstract][Full Text] [Related]
2. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ
Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
[TBL] [Abstract][Full Text] [Related]
3. Alopecia areata in aging C3H/HeJ mice.
Sundberg JP; Cordy WR; King LE
J Invest Dermatol; 1994 Jun; 102(6):847-56. PubMed ID: 8006447
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma-deficient mice are resistant to the development of alopecia areata.
Freyschmidt-Paul P; McElwee KJ; Hoffmann R; Sundberg JP; Vitacolonna M; Kissling S; Zöller M
Br J Dermatol; 2006 Sep; 155(3):515-21. PubMed ID: 16911275
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies to hair follicles in C3H/HeJ mice with alopecia areata-like hair loss.
Tobin DJ; Sundberg JP; King LE; Boggess D; Bystryn JC
J Invest Dermatol; 1997 Sep; 109(3):329-33. PubMed ID: 9284100
[TBL] [Abstract][Full Text] [Related]
6. Fas-deficient C3.MRL-Tnfrsf6(lpr) mice and Fas ligand-deficient C3H/HeJ-Tnfsf6(gld) mice are relatively resistant to the induction of alopecia areata by grafting of alopecia areata-affected skin from C3H/HeJ mice.
Freyschmidt-Paul P; McElwee KJ; Botchkarev V; Kissling S; Wenzel E; Sundberg JP; Happle R; Hoffmann R
J Investig Dermatol Symp Proc; 2003 Jun; 8(1):104-8. PubMed ID: 12895005
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice.
Freyschmidt-Paul P; Sundberg JP; Happle R; McElwee KJ; Metz S; Boggess D; Hoffmann R
J Invest Dermatol; 1999 Jul; 113(1):61-8. PubMed ID: 10417620
[TBL] [Abstract][Full Text] [Related]
8. Effects of the Lexington LaserComb on hair regrowth in the C3H/HeJ mouse model of alopecia areata.
Wikramanayake TC; Rodriguez R; Choudhary S; Mauro LM; Nouri K; Schachner LA; Jimenez JJ
Lasers Med Sci; 2012 Mar; 27(2):431-6. PubMed ID: 21739260
[TBL] [Abstract][Full Text] [Related]
9. [Alopecia areata in animal models--new insights into pathogenesis and treatment of a T cell-mediated autoimmune disorder].
Freyschmidt-Paul P; Happle R; Hoffman R
J Dtsch Dermatol Ges; 2004 Apr; 2(4):260-73. PubMed ID: 16285322
[TBL] [Abstract][Full Text] [Related]
10. Alopecia areata in C3H/HeJ mice involves leukocyte-mediated root sheath disruption in advance of overt hair loss.
McElwee KJ; Silva K; Boggess D; Bechtold L; King LE; Sundberg JP
Vet Pathol; 2003 Nov; 40(6):643-50. PubMed ID: 14608017
[TBL] [Abstract][Full Text] [Related]
11. Topical mechlorethamine restores autoimmune-arrested follicular activity in mice with an alopecia areata-like disease by targeting infiltrated lymphocytes.
Tang L; Cao L; Bernardo O; Chen Y; Sundberg JP; Lui H; Chung S; Shapiro J
J Invest Dermatol; 2003 Mar; 120(3):400-6. PubMed ID: 12603852
[TBL] [Abstract][Full Text] [Related]
12. SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction.
Gao Z; Jin YQ; Wu W
Oncotarget; 2017 May; 8(20):33432-33443. PubMed ID: 28418931
[TBL] [Abstract][Full Text] [Related]
13. Transfer of CD8(+) cells induces localized hair loss whereas CD4(+)/CD25(-) cells promote systemic alopecia areata and CD4(+)/CD25(+) cells blockade disease onset in the C3H/HeJ mouse model.
McElwee KJ; Freyschmidt-Paul P; Hoffmann R; Kissling S; Hummel S; Vitacolonna M; Zöller M
J Invest Dermatol; 2005 May; 124(5):947-57. PubMed ID: 15854035
[TBL] [Abstract][Full Text] [Related]
14. Plasmacytoid dendritic cells as a possible key player to initiate alopecia areata in the C3H/HeJ mouse.
Ito T; Suzuki T; Sakabe JI; Funakoshi A; Fujiyama T; Tokura Y
Allergol Int; 2020 Jan; 69(1):121-131. PubMed ID: 31431342
[TBL] [Abstract][Full Text] [Related]
15. Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans.
Carroll JM; McElwee KJ; E King L; Byrne MC; Sundberg JP
J Invest Dermatol; 2002 Aug; 119(2):392-402. PubMed ID: 12190862
[TBL] [Abstract][Full Text] [Related]
16. Crisp1 and alopecia areata in C3H/HeJ mice.
Sundberg JP; Awgulewitsch A; Pruett ND; Potter CS; Silva KA; Stearns TM; Sundberg BA; Muñoz MW; Cuasnicu PS; King LE; Rice RH
Exp Mol Pathol; 2014 Dec; 97(3):525-8. PubMed ID: 25446841
[TBL] [Abstract][Full Text] [Related]
17. Induction of alopecia areata in C3H/HeJ mice using cryopreserved lymphocytes.
Hashimoto K; Yamada Y; Sekiguchi K; Matsuda S; Mori S; Matsumoto T
J Dermatol Sci; 2021 Jun; 102(3):177-183. PubMed ID: 33994063
[TBL] [Abstract][Full Text] [Related]
18. Induction of alopecia areata in C3H/HeJ mice using polyinosinic-polycytidylic acid (poly[I:C]) and interferon-gamma.
Shin JM; Choi DK; Sohn KC; Koh JW; Lee YH; Seo YJ; Kim CD; Lee JH; Lee Y
Sci Rep; 2018 Aug; 8(1):12518. PubMed ID: 30131581
[TBL] [Abstract][Full Text] [Related]
19. Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata).
Siebenhaar F; Sharov AA; Peters EM; Sharova TY; Syska W; Mardaryev AN; Freyschmidt-Paul P; Sundberg JP; Maurer M; Botchkarev VA
J Invest Dermatol; 2007 Jun; 127(6):1489-97. PubMed ID: 17273166
[TBL] [Abstract][Full Text] [Related]
20. Treatment with an anti-CD44v10-specific antibody inhibits the onset of alopecia areata in C3H/HeJ mice.
Freyschmidt-Paul P; Seiter S; Zöller M; König A; Ziegler A; Sundberg JP; Happle R; Hoffmann R
J Invest Dermatol; 2000 Oct; 115(4):653-7. PubMed ID: 10998138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
